Buoyed by the profit growth, Square Pharma’s board has recommended a 110 percent cash dividend, its highest in nine years
Square Pharmaceuticals Ltd recorded Tk 1,465 crore profit in the July-March period of the ongoing financial year, up around 9 percent year-on-year
Buoyed by the profit growth, Square Pharma’s board has recommended a 110 percent cash dividend, its highest in nine years
Square Pharmaceuticals Ltd recorded Tk 1,465 crore profit in the July-March period of the ongoing financial year, up around 9 percent year-on-year
